Arthur de Garidel, Angel Investor

Arthur de Garidel-Thoron is a TechBio founder and corporate development leader focused on advancing patient outcomes through cutting‑edge technologies. He currently serves as Head of Business Development at AIRNA, a venture‑backed RNA editing company developing transformative medicines with precision, flexibility, and reversibility. Arthur is also the Co‑Founder of Epigene Labs, an AI‑native techbio company that unifies omic data into disease atlases for oncology and complex diseases. Under his leadership as COO and board member, Epigene secured major partnerships with Servier and Institut Curie, raised €14M in seed funding, and received support from the European Innovation Council. Previously, Arthur led business and corporate development at Korro Bio, and today he continues to combine deep expertise in strategy, partnerships, and fundraising with a passion for innovation in healthcare. As an investor, he backed Brink Therapeutics in April 2025 (Seed Round), reflecting his commitment to supporting early‑stage ventures in biotech and precision medicine.